Skip to main content
. 2022 Feb 5;21:20. doi: 10.1186/s12933-022-01455-2

Fig. 3.

Fig. 3

Forest plots examining the efficacy endpoints of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure. Events in the analyses represent total number of events rather than time-to-event endpoint data. SGLT2: sodium-glucose cotransporter 2; HF: heart failure; KCCQ: Kansas City Cardiomyopathy Questionnaire; M–H: Mantel–Haenszel; CI: confidence interval